Literature DB >> 2474256

Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma.

S Sell1, H A Dunsford.   

Abstract

A review of the morphologic, autoradiographic, and phenotypic analysis of the cellular changes seen during induction of cancer of the liver in rats by chemical carcinogens is used to develop an alternative to the established hypothesis that chemically induced hepatocellular carcinoma arises from premalignant nodules. The authors propose that hepatocellular and ductular carcinomas arise from a pluripotent liver stem cell and that enzyme-altered foci and nodular changes are adaptive non-oncogenic responses to the toxic effects of carcinogens. It is further postulated that persistent nodules may provide an environment that nurtures development of neoplastic cells other than the altered hepatocytes that originally form the nodule. It is possible, however, that there may be more than one cellular lineage to hepatocellular cancer and that persistent nodules contain these different lineages.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474256      PMCID: PMC1879951     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  71 in total

1.  Morphologic identification by electron microscopy of "oval" cells in experimental hepatic degeneration.

Authors:  J W GRISHAM; W S HARTROFT
Journal:  Lab Invest       Date:  1961 Mar-Apr       Impact factor: 5.662

2.  Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3'-methyl-4-dimethylaminoazobenzene.

Authors:  E FARBER
Journal:  Cancer Res       Date:  1956-02       Impact factor: 12.701

3.  Bile ductular cells and the phenotypic heterogeneity of the population of hepatic non-parenchymal epithelial cells induced in rats by chemical carcinogens.

Authors:  S Yokoyama; M Satoh; B Lombardi
Journal:  Carcinogenesis       Date:  1986-07       Impact factor: 4.944

4.  The genesis of cancer with chemicals.

Authors:  E Farber
Journal:  Arch Pathol Lab Med       Date:  1980-10       Impact factor: 5.534

5.  Chemicals, evolution, and cancer development: Rous-Whipple Award Lecture.

Authors:  E Farber
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

Review 6.  Chemical carcinogenesis: a biologic perspective.

Authors:  E Farber
Journal:  Am J Pathol       Date:  1982-02       Impact factor: 4.307

7.  Localization of alpha1-fetoprotein and DNA-synthesis in liver cell populations during experimental hepatocarcinogenesis in rats.

Authors:  W D Kuhlmann
Journal:  Int J Cancer       Date:  1978-03-15       Impact factor: 7.396

8.  Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis.

Authors:  D B Solt; A Medline; E Farber
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

9.  Autoradiography of "oval cells" appearing rapidly in the livers of rats fed N-2-fluorenylacetamide in a choline devoid diet.

Authors:  S Sell; K Osborn; H L Leffert
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

10.  Monoclonal antibodies recognizing oval cells induced in the liver of rats by N-2-fluorenylacetamide or ethionine in a choline-deficient diet.

Authors:  D C Hixson; J P Allison
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

View more
  74 in total

1.  The stem cells of the liver--a selective review.

Authors:  K Aterman
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

Review 2.  Biology of the adult hepatic progenitor cell: "ghosts in the machine".

Authors:  Houda Darwiche; Bryon E Petersen
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

3.  TWEAK induces liver progenitor cell proliferation.

Authors:  Aniela Jakubowski; Christine Ambrose; Michael Parr; John M Lincecum; Monica Z Wang; Timothy S Zheng; Beth Browning; Jennifer S Michaelson; Manfred Baetscher; Manfred Baestcher; Bruce Wang; D Montgomery Bissell; Linda C Burkly
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

Review 4.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

Review 5.  Liver cancer stem cell markers: Progression and therapeutic implications.

Authors:  Jing-Hui Sun; Qing Luo; Ling-Ling Liu; Guan-Bin Song
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

Review 6.  Wound healing in the liver with particular reference to stem cells.

Authors:  M Alison; M Golding; C Sarraf
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

7.  The CD133+CD44+ precancerous subpopulation of oval cells is a therapeutic target for hepatocellular carcinoma.

Authors:  Yun-Wen Zheng; Tomonori Tsuchida; Taiki Shimao; Bin Li; Takanori Takebe; Ran-Ran Zhang; Yu Sakurai; Yasuharu Ueno; Keisuke Sekine; Naoto Ishibashi; Makiko Imajima; Takuji Tanaka; Hideki Taniguchi
Journal:  Stem Cells Dev       Date:  2014-06-26       Impact factor: 3.272

8.  Progenitor-derived hepatocellular carcinoma model in the rat.

Authors:  Jesper B Andersen; Roberto Loi; Andrea Perra; Valentina M Factor; Giovanna M Ledda-Columbano; Amedeo Columbano; Snorri S Thorgeirsson
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

9.  Integrins as differential cell lineage markers of primary liver tumors.

Authors:  R Volpes; J J van den Oord; V J Desmet
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Metalloproteinases 2 and 9 activity during promotion and progression stages of rat liver carcinogenesis.

Authors:  Kelly Silva Furtado; Paulo Wagner Pires; Luis Antonio Justulin; Maria Aparecida Marchesan Rodrigues; Sergio Luis Felisbino; Luis Fernando Barbisan
Journal:  J Mol Histol       Date:  2008-12-04       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.